| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6007185 | Clinical Neurology and Neurosurgery | 2012 | 8 Pages |
Abstract
Taken together, we demonstrate that resveratrol could inhibit prolactinoma cell proliferation, induce cell cycle block and apoptosis, and decrease prolactin production and release, and estrogen receptors mediate its antitumor effects. And thus, these results lead us to propose developing resveratrol as a novel therapeutic agent for treatment of prolactinoma.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Wang Chao, Hu Zhi-qiang, Chu Ming, Wang Zhi, Zhang Wei-guang, Wang Lai-zang, Li Chen-guang, Wang Jun-sheng,